IMR Press / CEOG / Volume 40 / Issue 3 / pii/1630388300920-1138794913

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 46 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Open Access Original Research
Surgical treatment outcomes of serious chronic tubo-ovarian abscess: a single-center series of 20 cases
Show Less
1 Departments of Obstetrics and Gynecology
2 Department of Biochemistry, Shimane University School of Medicine, Izumo (Japan)
Clin. Exp. Obstet. Gynecol. 2013, 40(3), 377–380;
Published: 10 September 2013
Abstract

In recent years, Shimane University Hospital has begun to see patients with pelvic inflammatory disease (PID) which has become severe and chronic after insufficient conservative treatment in primary or secondary medical care facilities. Serious chronic tubo-ovarian abscess (TOA) is complicated by intraperitoneal inflammatory adhesions to surrounding organs, so that it is difficult to determine the original anatomical position of organs at surgery. Forcible synechotomy can result in damage to the adhering organs and insufficient drainage after surgery can cause recurrence of inflammation. In order to increase the chances for a successful surgical treatment, careful preparation, such as preoperative administration of antibiotics and ureteral stent insertion are necessary. In addition, the chances for recurrence of inflammation can be lessened by thorough intraperitoneal irrigation and insertion of a drainage tube.
Keywords
Pelvic inflammatory disease
Tubo-ovarian abscess
Share
Back to top